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Abstract
Background: Endothelial lipase (EL) is a major determinant of high-density lipoprotein-cholesterol (HDL-C)
metabolism, but the association of endothelial lipase gene (LIPG) polymorphism and serum HDL-C levels is scarce
and conflicting in diverse populations. Bai Ku Yao is an isolated subgroup of the Yao minority in China. This study
was designed to detect the association of LIPG 584C > T (rs2000813) polymorphism and several environmental
factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
Methods: A total of 645 subjects of Bai Ku Yao and 638 participants of Han Chinese were randomly selected from
our previous stratified randomized cluster samples. Genotyping of the LIPG 584C > T was performed by polymerase
chain reaction and restriction fragment length polymorphism combined with gel electrophoresis, and then
confirmed by direct sequencing.
Results: The levels of serum total cholesterol (TC), HDL-C, low-density lipoprotein cholesterol (LDL-C) and
apolipoprotein (Apo) AI and ApoB were lower in Bai Ku Yao than in Han (P < 0.05 - 0.001). The frequency of C and
T alleles was 73.5% and 26.5% in Bai Ku Yao, and 67.9% and 32.1% in Han (P < 0.01); respectively. The frequency of
CC, CT and TT genotypes was 50.4%, 46.2% and 3.4% in Bai Ku Yao, and 41.4%, 53.1% and 5.5% in Han (P < 0.01);
respectively. Serum HDL-C levels in both ethnic groups were different among the three genotypes (P < 0.05 for
each). Serum TC levels in both ethnic groups were also different between the CC and CT/TT genotypes (P < 0.05
for each). The T allele carriers had higher serum HDL-C and TC levels than the T allele noncarriers. Multivariate
logistic regression analysis showed that the levels of HDL-C and ApoB were correlated with genotypes in Bai Ku
Yao (P < 0.05 for each), whereas the levels of TC and HDL-C were associated with genotypes in Han Chinese (P <
0.05 and P < 0.01). Serum lipid parameters were also correlated with several environmental factors in the both
ethnic groups.
Conclusions: The frequency of LIPG 584T allele is lower in Bai Ku Yao than in Han Chinese. The LIPG 584T allele is
associated with increased serum HDL-C, TC and ApoB levels. The differences in serum HDL-C, TC and ApoB levels
between the two ethnic groups might partly result from different genotypic and allelic frequencies of LIPG 584C >
T or different LIPG-enviromental interactions.
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Many epidemiological and clinical studies have shown
that dyslipidemia, including high levels of plasma or
serum total cholesterol (TC) [1,2], triglyceride (TG)
[3,4], low-density lipoprotein cholesterol (LDL-C) [5,6]
and apolipoprotein B (ApoB) [7,8], and low levels of
high-density lipoprotein cholesterol (HDL-C) and
ApoAI [9,10], is strongly associated with an increased
risk of coronary artery disease (CAD). It is generally
accepted that dyslipidemia is a polygenic disease with
pathogenic contributions from both genetic and envir-
onmental risk factors such as demographics [11], diet
[12], alcohol consumption [13], cigarette smoking
[13,14], obesity [15], physical activity [16], hypertension
[17]. Data from family and twin studies suggest that
genetic variation accounts for 40%-60% of the individual
variation in serum lipid concentrations [18-20].
Endothelial lipase (protein: EL; gene: LIPG)i sam e m -
ber of the triglyceride lipase family of proteins that
includes lipoprotein lipasea n dh e p a t i cl i p a s e ,a n di t
exhibits a conserved catalytic triad, heparin-binding
properties, lipid-binding domains, and cysteine residues
[21]. EL is produced by endothelial cells as well as by
other cell types such as macrophages and hepatocytes.
LIPG spans 10 exons and 9 introns and encodes a poly-
peptide of 500 amino acids. The EL cDNA shares 45%
homology with lipoprotein lipase and 40% homology
with hepatic lipase and contains three conserved cataly-
tic residues [21,22]. EL has phospholipase activity, but
relatively little triglyceride lipase activity (phospholipase
to triglyceride lipase ratio, 1.6) [23-25]. It has been
demonstrated that overexpression of EL in the liver by
adenovirus-mediated gene transfer results in a signifi-
cant decrease in HDL-C and ApoAI [21]. Among the
genetic variants of the LIPG, a common single nucleo-
tide polymorphism (SNP), 584C > T, in exon 3 deserved
greater scrutiny, as it was responsible for a significant
amino acid change (584C > T, Thr111Ile) that could
potentially be associated with altered EL activity. Studies
in mouse models showed that a decrease in EL expres-
sion and activity, by gene deletion of LIPG in knockout
mice [26,27] and by antibody inhibition [28], resulted in
significant increases in plasma HDL-C in mice. Further-
more, overexpression of LIPG in transgenic mice
resulted in decreased plasma HDL [21]. The LIPG 584C
> T (rs2000813) polymorphism in humans has been
f o u n dt ob ea s s o c i a t e dw i t h modifications of serum
HDL-C levels in some studies [27,29-32] but not in
others [33-37].
Han is the largest ethnic group and Yao is the ele-
venth largest minority among the 55 minority groups
according to the population size. Bai Ku Yao (White-
trouser Yao), an isolated ethnic subgroup of the Yao
minority, is named so because all the men wear white
knee-length knickerbockers. The population size is
about 30000. Because of isolation from the other ethnic
groups, the special customs and cultures including their
clothing, intra-ethnic marriages, dietary habits, and life-
style are still completely preserved to the present day. In
several previous epidemiologic study, we found that the
serum lipid levels and the prevalence of hyperlipidemia
were lower in Bai Ku Yao than in Han Chinese from the
same area [38,39]. This ethnic difference in serum lipid
profiles is still not well known. We hypothesized that
some gene polymorphisms may be different between the
two ethnic groups. Therefore, in the present study, we
examined the associations of LIPG 584C > T poly-
morphism and several environmental factors with serum
lipid levels in the Guangxi Bai Ku Yao and Han
populations.
Materials and methods
Study population
A total of 645 subjects of Bai Ku Yao who reside in Lihu
and Baxu villages in Nandan County, Guangxi Zhuang
Autonomous Region, People’sR e p u b l i co fC h i n aw e r e
randomly selected from our previous stratified rando-
mized cluster samples [38,39]. The ages of the subjects
ranged from 15 to 85 years, with an average age of
40.25 ± 15.28 years. There were 337 males (52.25%) and
308 females (47.75%). All subjects were rural agricultural
workers. The subjects accounted for 2.15% of total Bai
Ku Yao population. During the same period, a total of
638 people of Han Chinese who reside in the same vil-
l a g e sw e r ea l s or a n d o m l ys elected from our previous
stratified randomized cluster samples [38,39]. The mean
age of the subjects was 40.53 ± 15.54 years (range 15 to
82). There were 343 men (53.76%) and 295 women
(46.24%). All of them were also rural agricultural work-
ers. All study subjects had no evidence of any chronic
illness, including hepatic, renal, or thyroid. The partici-
pants with a history of heart attack or myocardial infarc-
tion, stroke, congestive heart failure, diabetes or fasting
blood glucose ≥7.0 mmol/L determined by glucose
meter have been excluded. The participants were not
taking medications known to affect serum lipid levels
(lipid-lowering drugs such as statins or fibrates, beta-
blockers, diuretics, or hormones). The present study was
approved by the Ethics Committee of the First Affiliated
Hospital, Guangxi Medical University. Informed consent
was obtained from all subjects after they received a full
explanation of the study.
Epidemiological survey
The survey was carried out using internationally stan-
dardized methods, following a common protocol [40].
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and lifestyle factors was collected with standardized
questionnaires. The alcohol information included ques-
t i o n sa b o u tt h en u m b e ro fl i a n g s( a b o u t5 0g )o fr i c e
wine, corn wine, rum, beer, or liquor consumed during
the preceding 12 months. Alcohol consumption was
categorized into groups of grams of alcohol per day: <25
and ≥25. Smoking status was categorized into groups of
cigarettes per day: <20 and ≥20. At the physical exami-
nation, several anthropometric parameters, such as
height, weight, and waist circumference were measured.
Sitting blood pressure was measured three times with
the use of a mercury sphygmomanometer after the sub-
jects had a 5-minute rest, and the average of the three
measurements was used for the blood pressure levels.
Systolic blood pressure was determined by the first Kor-
otkoff sound, and diastolic blood pressure by the fifth
Korotkoff sound. Body weight, to the nearest 50 grams,
was measured using a portable balance scale. Subjects
were weighed without shoes and in a minimum of cloth-
ing. Height was measured, to the nearest 0.5 cm, using
a portable steel measuring device. From these two
measurements body mass index (BMI, kg/m
2)w a s
calculated.
Laboratory methods
A venous blood sample of 8 ml was obtained from all
subjects between 8 and 11 AM, after at least 12 hours
of fasting, from a forearm vein after venous occlusion
for few seconds in a sitting position. A part of the sam-
ple (3 ml) was collected into glass tube and used to
determine serum lipid levels. Another part of the sample
(5 ml) was transferred to tubes with anticoagulate solu-
tion (4.80 g/L citric acid, 14.70 g/L glucose, and 13.20
g/L tri-sodium citrate) and used to extract DNA. Imme-
diately following clotting serum was separated by centri-
fugation for 15 minutes at 3000 rpm. The levels of TC,
TG, HDL-C, and LDL-C in samples were determined by
enzymatic methods with commercially available kits,
Tcho-1, TG-LH (RANDOX Laboratories Ltd., Ardmore,
Diamond Road, Crumlin Co. Antrim, United Kingdom,
BT29 4QY), Cholestest N HDL, and Cholestest LDL
(Daiichi Pure Chemicals Co., Ltd., Tokyo, Japan),
respectively. Serum ApoAI and ApoB levels were
detected by the immunoturbidimetric immunoassay
using a commercial kit (RANDOX Laboratories Ltd.).
All determinations were performed with an autoanalyzer
(Type 7170A; Hitachi Ltd., Tokyo, Japan) in the Clinical
Science Experiment Center of the First Affiliated Hospi-
tal, Guangxi Medical University [38,39].
Genetic analysis
Genomic DNA was isolated from peripheral blood leuko-
cytes using the phenol-chloroform method [41,42]. The
extracted DNA was stored at 4°C until analysis. Genotyp-
ing of the LIPG 584C > T was performed by polymerase
chain reaction and restriction fragment length polymorph-
ism (PCR-RFLP) [37]. LIPG genotypes were determined
using mutagenic oligonucleotide primers with sequences
5’-CATGAGCTGAGATTGTTGTCAGTGC-3’ and 5’-
CAGTCAACCACAACTACATTGGCGTCTTTCTCT-
CAT-3’ (Sangon, Shanghai, People’s Republic of China).
Each amplification reaction was performed in a total
volume of 25 mL, containing 10 × PCR buffer (1.8 mM
MgCl2)2 . 5μL, 1 U Taq polymerase, 2.5 mmol/L of each
dNTP (Tiangen, Beijing, People’s Republic of China) 2.0
μL, 20 pmol/L of each primer and 50 ng of genomic DNA,
processing started with 94°C for 5 min and 30 cycles at
94°C for 30 s, 58.8°C for 30 s and 72°C for 30 s. This was
followed by a final extension at 72°C for 4 min. Then 10 U
of NdeI enzyme was added directly to the PCR products
(10 μL) and digested at 37°C overnight. After restriction
enzyme digestion of the amplified DNA, genotypes were
identified by electrophoresis on 3% agarose gels and visua-
lized with ethidium-bromide staining ultraviolet illumina-
tion. Genotypes were scored by an experienced reader
blinded to epidemiological and serum lipid data. Six sam-
ples (CC, CT and TT genotypes in two, respectively)
detected by the PCR-RFLP were also confirmed by direct
sequencing. The PCR product was purified by low melting
point gel electrophoresis and phenol extraction, and then
the DNA sequence was analyzed in Shanghai Sangon
Biological Engineering Technology & Services Co., Ltd.,
People’s Republic of China.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoAI and ApoB levels, and the ratio of ApoAI to
ApoB in our Clinical Science Experiment Center were
3.10-5.17, 0.56-1.70, 0.91-1.81, 2.70-3.20 mmol/L,
1.00-1.78, 0.63-1.14 g/L, and 1.00-2.50; respectively.
The individuals with TC > 5.17 mmol/L and/or TG >
1.70 mmol/L were defined as hyperlipidemic [38,39].
Hypertension was diagnosed according to the criteria
of 1999 World Health Organization-International
Society of Hypertension Guidelines for the manage-
ment of hypertension [43,44]. The diagnostic criteria
of overweight and obesity were according to the Coop-
erative Meta-analysis Group of China Obesity Task
Force. Normal weight, overweight and obesity were
defined as a BMI <24, 24-28, and > 28 kg/m
2; respec-
tively [45].
Statistical analyses
Epidemiological data were recorded on a pre-
designed form and managed with Excel software. All
statistical analyses were done with the statistical soft-
ware package SPSS 13.0 (SPSS Inc., Chicago, Illinois).
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standard deviation (serum TG levels were presented
as medians and interquartile ranges). Qualitative vari-
ables were presented as percentages. Allele frequency
was determined via direct counting, and the standard
goodness-of-fit test was used to test the Hardy-Wein-
berg equilibrium. Differences in genotype distribution
between the ethnic groups were obtained using the
chi-square test. The difference in general characteris-
tics between Bai Ku Yao and Han Chinese was tested
by the Student’su n p a i r e dt-test (TG by the Wil-
coxon-Mann-Whitney test). The association of geno-
types with serum lipid parameters was tested by
analysis of covariance (TG by the Kruskal-Wallis test
or the Wilcoxon-Mann-Whitney test). Sex, age, BMI,
blood pressure, alcohol intake, cigarette smoking
were adjusted for the statistical analysis. In order to
evaluate the association of serum lipid levels with
genotypes and several environment factors, multivari-
ate logistic regression analysis was also performed in
the combined population of Bai Ku Yao and Han, Bai
Ku Yao, and Han; respectively. A P value of less than
0.05 was considered statistically significant.
Results
General characteristics and serum lipid levels
Table 1 gives the general characteristics and serum lipid
levels between the Bai Ku Yao and Han populations.
The levels of body height, weight, BMI, systolic blood
pressure, diastolic blood pressure, pulse pressure, serum
T C ,H D L - C ,L D L - C ,A p o A I ,a n dA p o Bw e r el o w e ri n
Bai Ku Yao than in Han (P < 0.05 - 0.001), whereas the
percentage of subjects who consumed alcohol was
higher in Bai Ku Yao than in Han (P < 0.05). There was
no significant difference ins e r u mT Gl e v e l s ,a g es t r u c -
ture, the percentage of subjects who smoked cigarettes,
and the ratio of ApoAI to ApoB, or the ratio of male to
female between the two ethnic groups (P > 0.05).
Results of electrophoresis and genotyping
After the genomic DNA of the samples was amplified by
PCR and imaged by 3% agarose gel electrophoresis, the
purpose gene of 254 bp nucleotide sequences could be
found in all samples (Figure 1). The genotypes identified
were named according to the presence or absence of the
enzyme restriction sites, when a C to T transversion at
nucleotide position 584 of the LIPG. For the C allele,
Table 1 The general characteristics and serum lipid levels between the Bai Ku Yao and Han populations
Parameter Bai Ku Yao Han Chinese t (c
2) P
Number 645 638 - -
Male/female 337/308 343/295 0.295 0.587
Age (years) 40.25 ± 15.28 40.53 ± 15.54 -0.327 0.743
Height (cm) 153.04 ± 7.17 156.14 ± 7.97 -7.322 0.000
Weight (kg) 51.53 ± 7.15 54.83 ± 9.38 -7.079 0.000
Body mass index (kg/m
2) 21.97 ± 2.37 22.45 ± 3.23 -3.080 0.002
Systolic blood pressure (mmHg) 117.03 ± 16.07 120.89 ± 16.45 -4.251 0.000
Diastolic blood pressure (mmHg) 74.92 ± 9.11 76.46 ± 10.77 -2.767 0.006
Pulse pressure (mmHg) 42.11 ± 11.96 44.47 ± 11.26 -3.632 0.000
Cigarette smoking [n (%)]
Nonsmoker 451(69.9) 440(69.0)
<20 cigarettes/day 88(13.6) 80(12.5)
≥20 cigarettes/day 106(16.5) 118(18.5) 1.121 0.571
Alcohol consumption [n (%)]
Nondrinker 363(56.3) 400(62.7)
<25 g/day 183(28.4) 146(22.9)
≥25 g/day 99(15.3) 92(14.4) 6.174 0.046
Total cholesterol (mmol/L) 4.28 ± 0.93 4.68 ± 1.05 -7.315 0.000
Triglyceride (mmol/L)
a 1.02(0.71) 0.98(0.73) -0.450 0.653
HDL-C (mmol/L) 1.62 ± 0.42 1.87 ± 0.49 -9.779 0.000
LDL-C (mmol/L) 2.51 ± 0.77 2.60 ± 0.77 -2.148 0.032
Apolipoprotein (Apo) AI (g/L) 1.28 ± 0.33 1.41 ± 0.27 -7.862 0.000
ApoB (g/L) 0.83 ± 0.23 0.88 ± 0.22 -4.115 0.000
ApoAI/ApoB 1.67 ± 0.77 1.70 ± 0.53 -0.575 0.565
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
aThe value of TG was presented as median (interquartile range). The
difference between the two ethnic groups was determined by the Wilcoxon-Mann-Whitney test.
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tion produced 217- and 37-bp products. Thus, the CC
genotype is homozygote for the absence of the site
(band at 254 bp), CT genotype is heterozygote for the
absence and presence of the site (bands at 254-, 217-
and 37-bp), and TT genotype is homozygote for the pre-
sence the site (bands at 217- and 37-bp; Figure 1). The
37 bp fragment was invisible in the gel owing to its fast
migration speed. The genotype distribution was consis-
tent with the Hardy-Weinberg equilibrium.
Genotypic and allelic frequencies
The frequencies of the LIPG 584C > T alleles and geno-
types are shown in Table 2. The frequencies of C and T
alleles were 73.5% and 26.5% in Bai Ku Yao, and 67.9%
and 32.1% in Han (P < 0.01); respectively. The frequen-
cies of CC, CT and TT genotypes were 50.4%, 46.2%
and 3.4% in Bai Ku Yao, and 41.4%, 53.1% and 5.5% in
Han (P < 0.01); respectively.
Results of sequencing
The results shown as CC, CT and TT genotypes by
PCR-RFLP, CC, CT and TT genotypes were also con-
firmed by sequencing (Figure 2).
Genotypes and serum lipid levels
As shown in Table 3, the levels of HDL-C in both eth-
nic groups were different among the three genotypes
(P < 0.05 for each). The levels of TC, HDL-C and
ApoAI in Bai Ku Yao and the levels of TC and TG in
Han were different between CC and CT/TT genotypes
(P < 0.05 for all). The T allele carriers had higher serum
lipid levels than the T allele noncarriers. There was no
significant difference in the levels of LDL-C, ApoB, and
the ratio of ApoAI to ApoB among the three genotypes
in the both ethnic groups (P > 0.05 for all).
Risk factors for the lipid parameters
Multivariate logistic regression analysis showed that the
levels of HDL-C and ApoB were correlated with geno-
types in Bai Ku Yao (P < 0.05 for each), whereas the
levels of TC and HDL-C were associated with genotypes
in Han Chinese (P < 0.05 and < 0.01; respectively).
Serum lipid parameters were also correlated with sex,
age, weight, BMI, alcohol consumption, cigarette smok-
ing, and blood pressure in the both ethnic groups
(Table 4).
Discussion
The present study shows that the serum levels of TC,
HDL-C, LDL-C, ApoAI and ApoB were lower in Bai Ku
Yao than in Han Chinese. There were no significant dif-
ferences in serum TG levels and the ratio of ApoAI to
ApoB between the two ethnic groups. These findings
are consistent with those of our previous epidemiologi-
cal studies [38,39]. It is well known that dyslipidemia is
a complex trait caused by multiple environmental and
genetic factors and their interactions. Bai Ku Yao is a
special subgroup of the Yao minority in China. Strict
intra-ethnic marriages have been performed in this
population from time immemorial. Therefore, we
believed that the hereditary characteristics and some
lipid metabolism-related gene polymorphisms in this
population may be different from those in Han Chinese.
The frequency of the rare allele (584T) was found to
be 10.3% in blacks, 31.2% in white controls, 32.6% in
whites with high HDL-C [34], 26% in the Lipoprotein
and Coronary Atherosclerosis Study (LCAS) population
(white individuals including 27 or 7% African Ameri-
cans)[27], 26% in Japanese [37], and 21.6% in healthy
school-aged Japanese children [33]. In the present study,
we showed that the frequency of the T allele and CT
and TT genotypes was lower in Bai Ku Yao than in
Han. The frequency of the T allele in Bai Ku Yao was
Table 2 Genotypic and allelic frequencies of the LIPG
584C > T polymorphism between the Bai Ku Yao and
Han population [n (%)]
Group n
Genotype Allele
CC CT TT C T
Bai Ku Yao 645 325(50.4) 298(46.2) 22(3.4) 948(73.5) 342(26.5)
Han Chinese 638 264(41.4) 339(53.1) 35(5.5) 867(67.9) 409(32.1)
c
2 - 11.883 9.516
P - 0.003 0.002
Figure 1 Genotyping of the LIPG 584C > T polymorphism. Lane
M, 50 bp Marker Ladder; lane 1, the PCR product of the sample
(254 bp); lanes 2 and 3, CC genotype (254 bp); lanes 4 and 5, CT
genotype (254-, 217- and 37-bp); and lanes 6 and 7, TT genotype
(217- and 37-bp). The 37 bp fragment was invisible in the gel
owing to its fast migration speed.
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trols [34]. These results indicate that the LIPG 584C >
T polymorphism may have significant difference in allele
frequencies among diverse ethnics and between control
subjects and those with high HDL-C levels. However,
McCoy et al. [24] found that EL is completely inactive
in vitro in the presence of serum, and deLemos et al.
[34] found no significant difference in allele frequencies
of six polymorphisms in the LIPG between individuals
with normal and those with high HDL-C. Thus, the
physiological role of EL in lipoprotein metabolism, if
any, is still unknown.
The association between the LIPG 584C > T poly-
morphism and plasma or serum lipid levels in humans
has not been fully elucidated. In the present study, we
found a significant association between the LIPG 584C
> T polymorphism and serum HDL-C and TC levels. In
the both Bai Ku Yao and Han populations, we can
detect an increased prevalence of the T allele in subjects
with higher serum HDL-C and TC levels. Previous
association studies of this SNP with plasma HDL-C
levels produced conflicting results. Several studies have
reported significant association between the LIPG 584C
> T polymorphism and HDL-C levels [27,29-32],
whereas several reports failed to find a significant
genetic effect on HDL-C concentrations [33-37]. Ma
and colleagues [27] reported that the LIPG 584C > T
polymorphism was associated with an increase in HDL-
C among 372 participants. The patients with the T T
genotype have a 14% higher mean HDL-C compared
with those with the CC genotype. Yamakawa-Kobayashi
et al. [33] failed to detect an association of the LIPG
584C > T with HDL-C levels in 340 Japanese children.
Paradis and co-workers [46] found an association of the
LIPG 584C > T with increased levels of the HDL3 sub-
fraction in 281 females. Halverstadt et al. [32] found an
association of the LIPG 584C > T with NMR measure-
ments of HDL size in 83 healthy elderly participants but
not with overall HDL-C levels. Mank-Seymour et al.
[29] showed a weak association of the LIPG 584C > T
Figure 2 A part of the nucleotide sequence of the LIPG 584C > T polymorphism. (A) CC genotype; (B) CT genotype; (C) TT genotype
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et al. [30] found a weak association of the LIPG 584C >
T with HDL-C levels in 541 Japanese Americans. Tang
et al. [47] found a weak association of the LIPG 584C >
T with increased HDL-C in 265 Chinese CAD cases and
controls. The data by Edmondson et al. [36] from a
combined sample of 3,845 participants, and functional
studies of the variant definitively establish that the LIPG
584C > T is not associated with HDL-C and in vitro
studies show that it has normal lipolytic activity. The
reason for these conflicting results is not yet known.
The 584C > T SNP results in an amino acid change
(from a polar to nonpolar amino acid) that occurs in a
relatively poorly conserved area of the EL sequence, far
from important sites encoding for the catalytic activity
o fd e f i n i n gt h et e r t i a r ys t r u c t u r eo ft h ee n z y m e[ 4 8 ] .
The high prevalence of the minor allele also suggests
that it may not have a large effect on plasma HDL-C
levels in the general population [46]. In a previous
study, however, Shimizu et al. [37] found no significant
association between the LIPG 584C > T polymorphism
and HDL-C levels, but multivariate regression analyses
showed that the association of the LIPG 584T allele
with acute myocardial infarction was statistically signifi-
cant and independent of other risk factors when age,
sex, hypertension, hypercholesterolemia, and diabetes
mellitus were included in the analyses. Thus, the LIPG
584C > T polymorphism may be involved in the patho-
genesis of acute myocardial infarction. In LCAS there
was also a strong association of the LIPG 584C > T
polymorphism with the ratios of HDL-C/LDL-C and
ApoAI/ApoB, and the mean plasma ApoCIII concentra-
tion [27]. In the present study, we also showed that the
levels of TC and ApoAI in Bai Ku Yao and the levels of
TC and TG in Han were different between the CC and
CT/TT genotypes. The T allele carriers had higher
serum lipid levels than the T allele noncarriers. In mul-
tivariate logistic regression analysis, the levels of HDL-C
and ApoB were correlated with genotypes in Bai Ku
Yao, whereas the levels of TC and HDL-C were asso-
ciated with genotypes in Han Chinese. These results
suggest that the LIPG 584C > T polymorphism can also
influence other serum lipid parameters except HDL-C
in our populations.
As mentioned above, plasma lipid concentration is
highly heritable but is also modifiable by environmental
factors including demographics [11], diet [12], alcohol
consumption [13], cigarette smoking [13,14], obesity
[15], exercise [16], hypertension [17]. These factors
could explain why the association between HDL-C con-
centration and the LIPG 584C > T polymorphism was
not observed in some previous studies. For example,
heavy smokers have, on average, 9% lower HDL-C levels
than matched nonsmokers [14]. Obesity is one of the
Table 3 Genotypic frequencies of the LIPG 584C > T and serum lipid levels between the Bai Ku Yao and Han
populations
Genotype n TC (mmol/L) TG (mmol/L)
a HDL-C (mmol/L) LDL-C (mmol/L) ApoAI (g/L) ApoB (g/L) ApoAI/ApoB
Bai Ku Yao
CC 325 4.20 ± 0.87 1.02(0.65) 1.58 ± 0.40 2.48 ± 0.71 1.25 ± 0.32 0.82 ± 0.22 1.63 ± 0.70
CT 298 4.34 ± 1.00 1.02(0.77) 1.66 ± 0.45 2.52 ± 0.83 1.30 ± 0.34 0.83 ± 0.23 1.71 ± 0.83
TT 22 4.51 ± 0.71 1.08(0.70) 1.78 ± 0.41 2.58 ± 0.63 1.40 ± 0.37 0.88 ± 0.25 1.76 ± 0.88
F - 2.114 1.160 3.318 0.171 2.536 0.381 0.776
P - 0.122 0.314 0.037 0.843 0.080 0.683 0.461
CC 325 4.20 ± 0.87 1.02(0.65) 1.58 ± 0.40 2.48 ± 0.71 1.25 ± 0.32 0.82 ± 0.22 1.63 ± 0.70
CT/TT 320 4.35 ± 0.98 1.03(0.77) 1.67 ± 0.45 2.53 ± 0.82 1.31 ± 0.34 0.83 ± 0.23 1.71 ± 0.83
F - 3.894 1.774 5.414 0.310 3.902 0.119 1.522
P - 0.049 0.183 0.020 0.578 0.049 0.731 0.218
Han Chinese
CC 264 4.57 ± 0.88 0.99(0.64) 1.85 ± 0.48 2.54 ± 0.71 1.39 ± 0.25 0.87 ± 0.21 1.70 ± 0.50
CT 339 4.77 ± 1.18 0.97(0.78) 1.88 ± 0.48 2.65 ± 0.82 1.42 ± 0.29 0.89 ± 0.22 1.69 ± 0.56
TT 35 4.75 ± 0.91 1.08(0.83) 2.09 ± 0.63 2.49 ± 0.67 1.46 ± 0.23 0.91 ± 0.22 1.70 ± 0.56
F - 2.959 2.781 3.904 1.951 1.549 1.215 0.012
P - 0.053 0.063 0.021 0.143 0.213 0.297 0.988
CC 264 4.57 ± 0.88 0.99(0.64) 1.85 ± 0.48 2.54 ± 0.71 1.39 ± 0.25 0.87 ± 0.21 1.70 ± 0.50
CT/TT 374 4.76 ± 1.15 0.98(0.79) 1.89 ± 0.50 2.63 ± 0.80 1.43 ± 0.28 0.89 ± 0.22 1.69 ± 0.56
F - 5.894 4.462 1.880 2.399 2.559 2.090 0.743
P - 0.015 0.035 0.171 0.122 0.110 0.149 0.389
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B; ApoAI/ApoB, the ratio of apolipoprotein AI to apolipoprotein B.
a The value of TG was presented as median (interquartile range). The difference
among the genotypes was determined by the Kruskal-Wallis test or the Wilcoxon-Mann-Whitney test.
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Lipid Relative factor Regression coefficient Standard error c
2 P Odds ratio 95%CI
Bai Ku Yao and Han
TC Ethnic group -0.559 0.149 14.085 0.000 0.572 0.427-0.766
Age 0.020 0.005 14.060 0.000 1.020 1.010-1.031
Body mass index 0.155 0.026 35.363 0.000 1.167 1.109-1.229
Systolic blood pressure 0.020 0.008 7.225 0.007 1.021 1.006-1.036
Pulse pressure -0.030 0.010 8.287 0.004 0.971 0.951-0.991
Alcohol consumption 0.210 0.096 4.780 0.029 1.234 1.022-1.490
TG Sex -0.665 0.182 13.347 0.000 0.514 0.360-0.735
Body mass index 0.169 0.027 40.311 0.000 1.184 1.124-1.247
Alcohol consumption 0.229 0.109 4.428 0.035 1.258 1.016-1.558
Genotype 0.354 0.158 4.996 0.025 1.425 1.045-1.943
HDL-C Ethnic group 1.221 0.333 13.414 0.000 3.390 1.764-6.515
Sex -1.209 0.346 12.244 0.000 0.298 0.152-0.588
Age -0.037 0.012 9.899 0.002 0.964 0.942-0.986
Alcohol consumption -0.612 0.270 5.157 0.023 0.542 0.320-0.920
LDL-C Age 0.025 0.006 15.978 0.000 1.026 1.013-1.039
Body mass index 0.174 0.029 35.023 0.000 1.190 1.123-1.261
Systolic blood pressure 0.020 0.009 5.034 0.025 1.020 1.003-1.038
Alcohol consumption -0.258 0.123 4.417 0.036 0.772 0.607-0.983
ApoAI Ethnic group 1.450 0.142 104.456 0.000 4.264 3.229-5.631
Sex -0.720 0.154 21.860 0.000 0.487 0.360-0.658
Age -0.033 0.005 45.064 0.000 0.968 0.958-0.977
Diastolic blood pressure -0.022 0.008 8.463 0.004 0.978 0.964-0.993
Alcohol consumption -0.773 0.118 42.820 0.000 0.462 0.366-0.582
ApoB Age 0.026 0.007 15.328 0.000 1.026 1.013-1.039
Body mass index 0.175 0.030 33.906 0.000 1.191 1.123-1.263
Pulse pressure -0.025 0.012 4.047 0.044 0.976 0.952-0.999
ApoAI/ApoB Ethnic group 0.704 0.181 15.128 0.000 2.022 1.418-2.884
Systolic blood pressure 0.012 0.005 5.190 0.023 1.012 1.002-1.022
Alcohol consumption 0.401 0.110 13.280 0.000 1.494 1.204-1.854
Bai Ku Yao
TC Age 0.029 0.008 14.523 0.000 1.030 1.014-1.045
Weight 0.077 0.015 25.488 0.000 1.080 1.048-1.113
TG Sex -0.833 0.229 13.299 0.000 0.435 0.278-0.680
Body mass index 0.197 0.045 19.055 0.000 1.218 1.115-1.331
HDL-C Sex -1.044 0.394 7.031 0.008 0.352 0.163-0.762
Age -0.033 0.014 5.814 0.016 0.968 0.943-0.994
Genotype -0.273 0.196 4.627 0.040 0.652 0.950-0.990
LDL-C Age 0.031 0.009 13.469 0.000 1.032 1.015-1.049
Weight 0.065 0.017 15.009 0.000 1.067 1.032-1.102
ApoAI Sex -0.546 0.208 6.898 0.009 0.579 0.386-0.871
Age -0.029 0.006 23.998 0.000 0.971 0.960-0.983
Alcohol consumption -0.800 0.151 27.987 0.000 0.449 0.334-0.604
ApoB Body mass index 0.189 0.055 11.470 0.001 1.207 1.084-1.345
Diastolic blood pressure 0.035 0.015 5.503 0.019 1.036 1.006-1.066
Genotype 0.479 0.231 4.283 0.038 1.614 1.026-2.539
ApoAI/ApoB Alcohol consumption 0.706 0.167 17.835 0.000 2.025 1.460-2.810
Han Chinese
TC Sex 0.775 0.227 11.633 0.001 2.170 1.390-3.386
Age 0.019 0.007 7.576 0.006 1.019 1.006-1.033
Weight 0.057 0.011 25.915 0.000 1.059 1.036-1.082
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Page 8 of 11most important factors in reducing HDL-C levels
[15,49]. Evidences of association in different populations
with different lifestyles and diet might suggest that the
associations found are robust to a large number of
genetic and environmental factors. In the present study,
we found that many confounding factors affect serum
lipid levels. Serum lipid parameters were correlated with
age, sex, alcohol consumption, cigarette smoking, BMI,
and blood pressure. These findings suggest that the
environmental factors also play an important role in
determing serum lipid levels in these populations. Dif-
ferences in serum lipid levels between the two ethnic
groups could be related to factors such as differences in
the genetic background, dietary patterns and lifestyle
factors and their interactions. Although Bai Ku Yao and
Han reside in the same region, there was significant dif-
ference in their diet and lifestyle. Corn was the staple
food and rice, soy, buckwheat, sweet potato, and pump-
kin products were the subsidiary foods in Bai Ku Yao.
Approximately 90% of the beverages were corn wine
and rum. The alcohol content is about 15% (v/v). They
are also accustomed to drink Hempseed soup. In con-
trast, rice was the staple food and corn, broomcorn,
potato, and taro products were the subsidiary foods in
Han. About 90% of the beverage was rice wine. The
content of alcohol is about 30% (v/v). The staple and
subsidiary foods are more favorable for serum lipid pro-
f i l e si nB a iK uY a ot h a ni nH a n .C o r nc o n t a i n sa b u n -
dant dietary fiber and plant protein. Dietary fiber can
decrease serum TC levels [50]. Plant protein can
promote the transportation and excretion of free choles-
terol. Soy protein intake is effective in reducing TC by
9.3%, LDL-C by 12.9%, and TG by 10.5% and in increas-
ing HDL-C by 2.4% [51]. Hypocholesterolemic activity
of buckwheat protein product is far stronger than that
of soy protein isolate [52]. Ludvik and his colleagues
[53] found that ingestion of 4 g/day caiapo (the extract
of white-skinned sweet potato) for 6 weeks reduces TC
and LDL-C in type 2 diabetic patients previously treated
by diet alone. Studies have demonstrated that pumpkin
is a useful therapy for hypercholesterolemia through
reducing oxidative stress and cholesterol levels [54]. A
number of experimental and clinical studies have
demonstrated that the beneficial effects of Hempseed or
Hempseed oil on serum lipid profiles include: decreasing
TC, TG and LDL-C levels [54,55], inhibiting lipid perox-
idation [55], reducing atherogenic index [56], and
increasing HDL-C levels [55,56].
Conclusion
The results of the present study show that the LIPG
584T allele frequency is lower in Bai Ku Yao than in
Han Chinese. A significant association is found between
the LIPG 584C > T polymorphism and serum HDL-C
and TC levels in the both ethnic groups. An increased
prevalence of the 584T allele in subjects with higher
serum HDL-C and TC levels is detected in the both
populations. The levels of HDL-C and ApoB were corre-
lated with genotypes in Bai Ku Yao, whereas the levels
of TC and HDL-C were associated with genotypes in
Table 4 Correlative factors for the lipid paramerers between the Bai Ku Yao and Han populations (Continued)
Systolic blood pressure 0.022 0.010 5.340 0.021 1.022 1.003-1.042
Pulse pressure -0.035 0.014 6.611 0.010 0.966 0.940-0.992
Alcohol consumption 0.286 0.140 4.150 0.042 1.331 1.011-1.751
Genotype 0.327 0.148 4.886 0.027 1.387 1.038-1.854
TG Weight 0.064 0.012 28.297 0.000 1.066 1.041-1.092
Systolic blood pressure 0.015 0.007 4.789 0.029 1.015 1.002-1.029
Cigarette smoking 0.318 0.132 5.855 0.016 1.375 1.062-1.779
HDL-C Age -0.062 0.023 7.056 0.008 0.940 0.898-0.984
Genotype -0.432 0.189 7.274 0.008 0.654 0.430-0.890
LDL-C Age 0.025 0.008 10.053 0.002 1.026 1.010-1.042
Body mass index 0.115 0.051 5.128 0.024 1.122 1.016-1.240
Alcohol consumption -0.449 0.177 6.438 0.011 0.638 0.451-0.903
ApoAI Sex -1.074 0.244 19.359 0.000 0.342 0.212-0.551
Age -0.043 0.008 27.185 0.000 0.958 0.942-0.973
Diastolic blood pressure -0.033 0.012 7.657 0.006 0.967 0.945-0.990
Alcohol consumption -0.558 0.186 8.973 0.003 0.572 0.397-0.825
ApoB Age 0.030 0.008 13.584 0.000 1.030 1.014-1.047
Body mass index 0.174 0.034 25.783 0.000 1.191 1.113-1.273
ApoAI/ApoB Systolic blood pressure 0.022 0.008 7.514 0.006 1.022 1.006-1.038.
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B; ApoAI/ApoB, the ratio of apolipoprotein AI to apolipoprotein B.
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Page 9 of 11Han Chinese. The differences in serum HDL-C, TC and
ApoB levels between the two ethnic groups might partly
result from different LIPG 584C > T polymorphism or
different LIPG-enviromental interactions.
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